ClinConnect ClinConnect Logo
Search / Trial NCT05894798

Acupuncture in Infantile Colic - A Randomised Trial.

Launched by REGION SKANE · Jun 7, 2023

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Infant Colic Pain Primary Healthcare Gastrointestinal

ClinConnect Summary

This clinical trial is exploring whether acupuncture can help reduce the symptoms of infant colic, a common condition where babies cry excessively, often for more than three hours a day. The study will involve 128 infants, aged 2 to 9 weeks, who are otherwise healthy and meet specific crying criteria. Half of the infants will receive acupuncture treatment, while the other half will not receive any acupuncture, and parents will not know which group their baby is in to ensure fairness in the results.

To participate, infants must be born at least 37 weeks into the pregnancy and must be experiencing significant crying as recorded in a diary. Babies who have lost weight or have had previous acupuncture treatments are not eligible. Throughout the trial, researchers will closely monitor the babies' crying patterns, bowel movements, and feeding habits to see if acupuncture makes a difference. This study is important because there are currently no effective treatments for infant colic, and it aims to provide more information about the potential benefits of acupuncture for this condition.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Otherwise healthy infants, born in week 37 or later, aged 2 - 9 weeks who, according to diary entries, scream/whine for at least 3 hours/day for at least 3 days in the same week. The child has undergone a medical examination at BB or later with no pathological findings. The child takes no medicines or only the dietary supplement Semper Magdroppar. At least one parent understands and speaks Swedish.
  • Exclusion Criteria:
  • Children who have lost more than one channel on their weight curve. Children who received acupuncture

About Region Skane

Region Skåne is a leading healthcare authority in Sweden, dedicated to advancing medical research and improving patient care through innovative clinical trials. Committed to fostering collaboration between researchers, healthcare professionals, and patients, Region Skåne aims to enhance the understanding of various health conditions and develop effective treatment strategies. With a focus on ethical standards and patient safety, the organization plays a pivotal role in shaping the future of healthcare in the region and beyond, ensuring that clinical trials are conducted with the highest level of scientific rigor and transparency.

Locations

Helsingborg, Region Skane, Sweden

Helsingborg, Skåne, Sweden

Patients applied

0 patients applied

Trial Officials

Veronica Milos Nymberg

Principal Investigator

Lund University/ Region Skane

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported